Stockscreener 앱 받기
108.33
1.25%
1.34
시간 외 거래:
108.33
전일 마감가:
$106.99
열려 있는:
$108.99
하루 거래량:
453.41K
Relative Volume:
0.93
시가총액:
$3.39B
수익:
$560.03M
순이익/손실:
$-150.66M
주가수익비율:
-22.29
EPS:
-4.86
순현금흐름:
$-87.43M
1주 성능:
+10.88%
1개월 성능:
+18.46%
6개월 성능:
+7.06%
1년 성능:
-2.01%
1일 변동 폭
$105.73
$108.99
1주일 범위
$86.99
$108.99
52주 변동 폭
$55.92
$124.11
Irhythm Technologies Inc Stock (IRTC) Company Profile
명칭
Irhythm Technologies Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
IRTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
108.33 | 3.39B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-03 | 재개 | Wells Fargo | Equal Weight |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-06-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Technologies Inc 주식(IRTC)의 최신 뉴스
iRhythm price target raised to $125 from $112 at Needham - Yahoo Finance
What You Can Learn From iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S - Simply Wall St
Long Term Trading Analysis for (IRTC) - Stock Traders Daily
2025-01-14 | Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies Reports Strong Growth and Innovation - Yahoo Finance
Needham & Company LLC Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price - Defense World
iRhythm Technologies, Inc. (NASDAQ:IRTC) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Analysts Set iRhythm Technologies, Inc. (NASDAQ:IRTC) Price Target at $108.45 - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Stock Price Down 7.7%What's Next? - MarketBeat
iRhythm stock remains a Buy at Needham, target increased on sales strength - Investing.com Canada
iRhythm Technologies Shares Fall 8% Following 2024, 2025 Outlooks - MarketWatch
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $112.00 - MarketBeat
2025-01-13 | Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies expects FY24 revenue slightly above guidance range - MSN
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
iRhythm Surpasses 2024 Revenue Targets, Projects Strong 2025 Growth with Record Zio Monitor Adoption - StockTitan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out - AccessWire
2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out | NDAQ:IRTC | Press Release - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation - AccessWire
2025-01-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Oppenheimer reiterates Outperform rating on iRhythm stock, highlighting strategic complementarity - Investing.com Australia
Vanguard Group Inc. Expands Stake in iRhythm Technologies Inc. - GuruFocus.com
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $120.00 at Oppenheimer - MarketBeat
Oppenheimer reiterates Outperform rating on iRhythm stock, highlighting strategic complementarity By Investing.com - Investing.com South Africa
2025-01-08 | iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
Tempus AI Stock Surges 23% in 6 Months: Should You Snap It Up Now? - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation - AccessWire
2025-01-06 | Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
Cardiac Monitoring Devices Market Size to Accumulate Around - GlobeNewswire
Wearable Patch Market Report 2025, with Profiles of Key Players Abbott, Medtronic, Dexcom, GlucoWatch, iRhythm Technologies, Insulet, Tactile Medical, VitalConnect, Qardio Myant & BioTelemetry - GlobeNewswire
Objective long/short (IRTC) Report - Stock Traders Daily
2025-01-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation - AccessWire
2025-01-03 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out | NDAQ:IRTC | Press Release - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach Out - AccessWire
iRhythm Technologies Inc (IRTC) Shares Up 3.74% on Jan 1 - GuruFocus.com
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation - AccessWire
IRhythm Technologies To Present At The 43rd Annual J.P. Morgan Healthcare Conference - Barchart
Wearable Heart Monitoring Devices Market Key Players Analysis - openPR
ECG Patch & Holter Monitor Market Report 2025- 2032| Industry Scope, Trends and Developments - WICZ
The Global Wearable Medical Devices Market to Grow Positively at a CAGR of 13.67% by 2030, DelveInsight - EIN News
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives $109.27 Average PT from Brokerages - MarketBeat
iRhythm price target raised to $111 from $85 at Truist - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $111.00 at Truist Financial - MarketBeat
State Street Corp Purchases 11,992 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Barclays PLC Buys 53,498 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Irhythm Technologies Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
0.57%
자본화:
|
볼륨(24시간):